Atlas Trials

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Clinical trial NCT00239135 · COMPLETED

Trial details

NCT number
NCT00239135
Sponsor
Peplin
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Keratosis
Start date
2005-09-01
Primary completion
2005-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.